Order Article Reprints

De Mattia E, Polesel J, Roncato R, Labriet A, Bignucolo A, Gagno S, Buonadonna A, D’Andrea M, Lévesque E, Jonker D, et al. IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm. Cancers. 2021; 13(7):1705. https://doi.org/10.3390/cancers13071705

De Mattia, Elena, Jerry Polesel, Rossana Roncato, Adrien Labriet, Alessia Bignucolo, Sara Gagno, Angela Buonadonna, Mario D’Andrea, Eric Lévesque, Derek Jonker, and et al. 2021. "IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm" Cancers 13, no. 7: 1705. https://doi.org/10.3390/cancers13071705

De Mattia, E., Polesel, J., Roncato, R., Labriet, A., Bignucolo, A., Gagno, S., Buonadonna, A., D’Andrea, M., Lévesque, E., Jonker, D., Couture, F., Guillemette, C., Cecchin, E., & Toffoli, G. (2021). IL15RA and SMAD3 Genetic Variants Predict Overall Survival in Metastatic Colorectal Cancer Patients Treated with FOLFIRI Therapy: A New Paradigm. Cancers, 13(7), 1705. https://doi.org/10.3390/cancers13071705